Zhou YN et al. |
Effect of amlodipine on the pharmacokinetics of tacrolimus in rats. |
2013 |
Xenobiotica |
pmid:23312000
|
Fujiyama N et al. |
Influence of carboxylesterase 2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. |
2009 |
Xenobiotica |
pmid:19274604
|
Tata PN et al. |
Species-dependent hepatic metabolism of immunosuppressive agent tacrolimus (FK-506). |
2009 |
Xenobiotica |
pmid:19604035
|
Zhang S et al. |
Effect of voriconazole and other azole antifungal agents on CYP3A activity and metabolism of tacrolimus in human liver microsomes. |
2012 |
Xenobiotica |
pmid:22106961
|
Lu XF et al. |
Use of a semi-physiological pharmacokinetic model to investigate the influence of itraconazole on tacrolimus absorption, distribution and metabolism in mice. |
2017 |
Xenobiotica |
pmid:27533047
|
Zhu L et al. |
Effects of CYP3A5 genotypes, ABCB1 C3435T and G2677T/A polymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patients. |
2015 |
Xenobiotica |
pmid:25869250
|
Patel CG et al. |
Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus. |
2013 |
Xenobiotica |
pmid:22934787
|
Chitnis SD et al. |
Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism. |
2013 |
Xenobiotica |
pmid:23278282
|
Miura M et al. |
Comparison of enantioselective disposition of rabeprazole versus lansoprazole in renal-transplant recipients who are CYP2C19 extensive metabolizers. |
2005 |
Xenobiotica |
pmid:16012079
|
Niioka T et al. |
Effects of CYP3A5 polymorphism and the tacrolimus 12 h concentration on tacrolimus-induced acute renal dysfunction in patients with lupus nephritis. |
2015 |
Xenobiotica |
pmid:26189776
|